EUVIMEDEUVIMED entdecken
Crossref

Sofosbuvir plus glecaprevir/pibrentasvir as salvage therapy after liver transplantation in NS5A inhibitor-experienced patients. A case series

Ignacio García-Juárez, Carlos Alonzo-García, Alan G Contreras, Fernanda Romero-Hernández, Maximiliano Servín-Rojas, Alfonso Fernández-Ramírez, Isaac Ruiz

Gaceta Médica de México · 2023

DOI: 10.24875/gmm.23000129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gaceta Médica de México, 2023. Verfasst von Ignacio García-Juárez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department and Liver Transplant Unit, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico. Hauptthemen laut MEDLINE: Liver Transplantation, Hepatitis C, Chronic, Hepatitis C.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationHepatitis C, ChronicHepatitis CHumansSofosbuvirSalvage TherapyAntiviral AgentsRetrospective StudiesAminoisobutyric AcidsCyclopropanesLeucineProlineQuinoxalinesSulfonamidesLactams, MacrocyclicBenzimidazolesPyrrolidines

Stichwörter der Autor:innen

Antivirales de acción directaDirect-acting antiviralsGlecaprevirHepatitis C virusLiver transplantationPibrentasvirRescue therapyTerapia de rescateTrasplante hepáticoVirus de hepatitis C

Substanzen

SofosbuvirAntiviral AgentsglecaprevirAminoisobutyric AcidsCyclopropanesLeucineProlineQuinoxalinesSulfonamidesLactams, Macrocyclic

Autor:innen und Institutionen

  • Gastroenterology Department and Liver Transplant Unit, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.
  • Deparment of Experimental Surgery. Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.
  • Service d'Hépatologie et de Transplantation Hépatique. Centre Hospitalier de l'Université de Montréal. Montréal, Canada.
  • Institut Mondor de Recherche Biomédicale, INSERM U955, Hôpital Henri Mondor, Université Paris-Est. Créteil, France.

Zitieren

APA

García-Juárez, I., Alonzo-García, C., Contreras, A. G., Romero-Hernández, F., Servín-Rojas, M., Fernández-Ramírez, A., & Ruiz, I. (2023). Sofosbuvir plus glecaprevir/pibrentasvir as salvage therapy after liver transplantation in NS5A inhibitor-experienced patients. A case series. Gaceta Médica de México. https://doi.org/10.24875/gmm.23000129

Vancouver

García-Juárez I, Alonzo-García C, Contreras AG, Romero-Hernández F, Servín-Rojas M, Fernández-Ramírez A, et al. Sofosbuvir plus glecaprevir/pibrentasvir as salvage therapy after liver transplantation in NS5A inhibitor-experienced patients. A case series. Gaceta Médica de México. 2023. doi:10.24875/gmm.23000129

BibTeX
@article{GarcaJurez2023,
  author = {García-Juárez, Ignacio and Alonzo-García, Carlos and Contreras, Alan G and Romero-Hernández, Fernanda and Servín-Rojas, Maximiliano and Fernández-Ramírez, Alfonso and Ruiz, Isaac},
  title = {Sofosbuvir plus glecaprevir/pibrentasvir as salvage therapy after liver transplantation in NS5A inhibitor-experienced patients. A case series},
  journal = {Gaceta Médica de México},
  year = {2023},
  doi = {10.24875/gmm.23000129}
}
Kostenlos starten →